JP2016520611A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520611A5
JP2016520611A5 JP2016516476A JP2016516476A JP2016520611A5 JP 2016520611 A5 JP2016520611 A5 JP 2016520611A5 JP 2016516476 A JP2016516476 A JP 2016516476A JP 2016516476 A JP2016516476 A JP 2016516476A JP 2016520611 A5 JP2016520611 A5 JP 2016520611A5
Authority
JP
Japan
Prior art keywords
activity
mpo
subjected
colon
colon tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016516476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520611A (ja
JP6867158B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NZ2014/000102 external-priority patent/WO2014193248A1/en
Publication of JP2016520611A publication Critical patent/JP2016520611A/ja
Publication of JP2016520611A5 publication Critical patent/JP2016520611A5/ja
Application granted granted Critical
Publication of JP6867158B2 publication Critical patent/JP6867158B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016516476A 2013-05-31 2014-05-30 ベータカゼインa2および腸の炎症の予防 Active JP6867158B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361829764P 2013-05-31 2013-05-31
US61/829,764 2013-05-31
PCT/NZ2014/000102 WO2014193248A1 (en) 2013-05-31 2014-05-30 Beta-casein a2 and prevention of inflammation of the bowel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019106371A Division JP7224242B2 (ja) 2013-05-31 2019-06-06 ベータカゼインa2および腸の炎症の予防

Publications (3)

Publication Number Publication Date
JP2016520611A JP2016520611A (ja) 2016-07-14
JP2016520611A5 true JP2016520611A5 (https=) 2021-02-12
JP6867158B2 JP6867158B2 (ja) 2021-04-28

Family

ID=51989162

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016516476A Active JP6867158B2 (ja) 2013-05-31 2014-05-30 ベータカゼインa2および腸の炎症の予防
JP2019106371A Active JP7224242B2 (ja) 2013-05-31 2019-06-06 ベータカゼインa2および腸の炎症の予防

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019106371A Active JP7224242B2 (ja) 2013-05-31 2019-06-06 ベータカゼインa2および腸の炎症の予防

Country Status (19)

Country Link
US (2) US20160113997A1 (https=)
EP (2) EP3542813A1 (https=)
JP (2) JP6867158B2 (https=)
KR (2) KR102282972B1 (https=)
CN (2) CN105407971B (https=)
AU (2) AU2014271423B2 (https=)
BR (1) BR112015029987A8 (https=)
CA (1) CA2913890C (https=)
CL (1) CL2015003507A1 (https=)
DK (1) DK3003485T3 (https=)
ES (1) ES2742306T3 (https=)
IL (2) IL242833B (https=)
MX (2) MX391963B (https=)
MY (1) MY179497A (https=)
PH (2) PH12015502674B1 (https=)
RU (1) RU2669553C2 (https=)
SG (2) SG10201709509RA (https=)
WO (1) WO2014193248A1 (https=)
ZA (1) ZA201508983B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3542813A1 (en) * 2013-05-31 2019-09-25 The A2 Milk Company Limited Beta-casein a2 and prevention of inflammation of the bowel
MX368912B (es) * 2013-07-12 2019-10-21 A2 Milk Co Ltd Beta-caseína a2 y reducción y prevención de síntomas de intolerancia a la lactosa.
GB2519101A (en) * 2013-10-09 2015-04-15 Nicoventures Holdings Ltd Electronic vapour provision system
US20170086481A1 (en) * 2014-06-03 2017-03-30 Abbott Laboratories Nutritional compositions comprising a lipophilic active ingredient
JP7137745B2 (ja) * 2015-05-22 2022-09-15 ズィ・エイツー・ミルク・カンパニー・リミテッド ベータカゼインa2および抗酸化能
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
WO2017171563A1 (en) 2016-03-30 2017-10-05 The A2 Milk Company Limited Beta-caseins and cognitive function
JP6873234B2 (ja) * 2016-09-30 2021-05-19 ズィ・エイツー・ミルク・カンパニー・リミテッド ベータカゼイン類および腸微生物叢
CN109563049B (zh) * 2016-10-14 2022-11-29 豪夫迈·罗氏有限公司 作为eaat3抑制剂的咪唑化合物
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
CN115708530B (zh) * 2022-11-15 2024-08-09 北大荒完达山乳业股份有限公司 一种促进消化舒适性并稳定血糖的孕产妇配方奶粉及其制备方法
CN117322467A (zh) * 2023-10-11 2024-01-02 东北农业大学 A2β-酪蛋白在制备功能性食品中的应用
WO2026003044A1 (en) * 2024-06-25 2026-01-02 Ntd Labs, S.L. Casein hydrolysate for treating crohn's disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2204245C (en) 1994-11-04 2008-07-22 Robert Bartlett Elliott Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
NZ306584A (en) * 1995-05-16 2000-02-28 Corran Norman Stuart Mclachlan Milk or dairy products derived from animals and which are free of beta casein
AU4266100A (en) * 1995-05-16 2000-10-12 Corran Norman Stuart Mclachlan Food product and process
WO1996036239A1 (en) 1995-05-16 1996-11-21 Corran Norman Stuart Mclachlan Food product and process
US6570060B2 (en) 1995-05-16 2003-05-27 Mclachlan Corran Norman Stuart Milk lacking β-casein A1
AU771754B2 (en) * 1999-06-29 2004-04-01 New Zealand Milk Institute Limited, The Prophylactic dietary supplement based on milk
NZ516712A (en) * 1999-06-29 2003-10-31 New Zealand Milk Inst Ltd Prophylactic dietary supplement based on milk
AU9037401A (en) 2000-09-08 2002-03-22 New Zealand Dairy Board Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
CA2444470A1 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20060280802A1 (en) 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
US7481127B2 (en) 2004-09-27 2009-01-27 Lester William T Continuously variable transmission using oscillating torque and one-way drives
WO2008041219A1 (en) * 2006-10-06 2008-04-10 Kerry Group Services International Limited A milk protein composition and use thereof
US8871276B2 (en) * 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
EP3542813A1 (en) * 2013-05-31 2019-09-25 The A2 Milk Company Limited Beta-casein a2 and prevention of inflammation of the bowel
MX368912B (es) * 2013-07-12 2019-10-21 A2 Milk Co Ltd Beta-caseína a2 y reducción y prevención de síntomas de intolerancia a la lactosa.

Similar Documents

Publication Publication Date Title
JP2016520611A5 (https=)
Spiridonakos et al. Parametric identification of a time-varying structure based on vector vibration response measurements
Tu et al. Luminescent biodetection based on lanthanide-doped inorganic nanoprobes
EA201270020A1 (ru) Определение риска развития атеросклеротической болезни сердца
CY1118864T1 (el) Μεθοδοι και συνθεσεις για μη επεμβατικη προγεννητικη διαγνωση εμβρυϊκων ανευπλοειδιων
WO2015176066A3 (en) Lpa-associated protein and rna expression
JP2014144959A5 (https=)
EP2576837A4 (en) CIRCULATING NUCLEIC ACID BIOMARKERS ASSOCIATED WITH PROSTATE CANCER
BR112017004899A2 (pt) detecção de proteínas mal dobradas
WO2013052505A3 (en) Methods and devices for assessing risk to a putative offspring of developing a condition
WO2016198833A3 (en) Methods for analysing a urine sample
WO2011143574A3 (en) Plasma biomarkers for diagnosis of alzheimer's disease
Sun et al. Potential involvement of the 18 kDa translocator protein and reactive oxygen species in apoptosis of THP-1 macrophages induced by sonodynamic therapy
WO2011036666A3 (en) Systems and methods for measuring translation of target proteins in cells
Rezq et al. Cardiac and renal SARS-CoV-2 viral entry protein regulation by androgens and diet: implications for polycystic ovary syndrome and COVID-19
Cattaneo et al. Optimal inference for instrumental variables regression with non-Gaussian errors
Sheikh et al. Right ventricular hypertrophy with early dysfunction: a proteomics study in a neonatal model
CL2012000323A1 (es) Un perno sensor electronico de desgaste, sistema y metodo para medir el deterioro de un componente solido sometido a desgaste.
ES2527703R2 (es) Inmunosensor electroquímico para la determinación cuantitativa de la micotoxina fb1
BR112013025287A2 (pt) ensaios com receptores de esteroide para detectar células tumorais
EP4365195A4 (en) Antibody against nucleocapsid protein of sars-cov-2
JP2012524884A5 (https=)
川合眞一 et al. Adiponectin Stimulates Prostaglandin E2 Production in Rheumatoid Synovial Fibroblasts.
Higuchi et al. 1J2-2 The trial of an array type acoustic impedance measuring device (Measurement Techniques, Imaging, Nondestructive Evaluation)
Mccartney et al. Human Cell Cultures as In Vitro Models to Elucidate How Pulmonary Diseases Alter Exhaled Breath Metabolites for Clinical Diagnostics